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Abstract
Background—The temporary or long-term xenotransplantation of pig organs into people would 
save thousands of lives each year if not for the robust human antibody response to pig 
carbohydrates. Genetically engineered pigs deficient in galactose α1,3 galactose (gene modified: 
GGTA1) and N-glycolylneuraminic acid (gene modified: CMAH) have significantly improved 
cell survival when challenged by human antibody and complement in vitro. There remains, 
however, a significant portion of human antibody binding.
Methods—To uncover additional xenoantigens we compared the asparagine-linked (N-linked) 
glycome from serum proteins of humans, domestic pigs, GGTA1 knockout pigs and GGTA1/
CMAH knockout pigs using mass spectrometry. Carbohydrate structures were determined with 
assistance from GlycoWorkbench, Cartoonist, and SimGlycan software by comparison to existing 
database entries and collision-induced dissociation fragmentation data.
Results—Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-
TOF-MS) analysis of reduced and solid-phase permethylated glycans resulted in the detection of 
high mannose, hybrid, and complex type N-linked glycans in the 1000 to 4500 m/z ion range. 
GGTA1/CMAH knockout pig samples had increased relative amounts of high-mannose, 
incomplete and xylosylated N-linked glycans. All pig samples had significantly higher amounts of 
core and possibly antennae fucosylation.
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Conclusions—We provide for the first time a comparison of the serum protein glycomes of the 
human, domestic pig and genetically modified pigs important to xenotransplantation.
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INTRODUCTION
Xenotransplantation of pig organs to humans is a potential solution to the human organ 
shortage. Pig xenografts are rejected, however, by human antibody binding to pig antigens 
followed by complement fixation and cell lysis; called antibody-mediated rejection (AMR). 
The most prominent antigen identified thus far is the oligosaccharide galactose-α-1,3 
galactose (aGal) (1,2). Genetic alteration of the α-1,3-galactosyl transferase gene that 
catalyzes the synthesis of aGal yielded a knockout pig with delayed AMR during 
transplantation to immunosuppressed non-human primates (3).
The second major barrier to using pig organs in xenotransplantation is the presence of the N-
glycolyl neuraminic acid (neu5Gc) in pigs. The addition of a glycolyl group to N-acetyl 
neuraminic acid (neu5Ac) is mediated by the enzyme cytidine monophosphate-N-
acetylneuraminic acid hydroxylase (CMAH). The production of Neu5Gc is absent in 
humans due to a mutation in the CMAH gene. Like aGal, the absence of neu5Gc in humans 
during immunologic education has resulted in the presence of IgG and IgM antibody that 
bind to these carbohydrate antigens and fix complement (4–6). We have recently produced a 
pig using zinc-finger endonucleases and somatic cell nuclear transfer that lacks production 
of the aGal and neu5Gc epitopes (4). Cells from the GGTA1/CMAH knockout pigs are 
bound by less antibody (IgG and IgM) and are rejected less vigorously by a complement-
based assay designed to estimate AMR (4). There remains, however, human IgG and IgM 
that bind to the GGTA1/CMAH knockout pig cells.
An analysis of the carbohydrate targets of human antibodies by carbohydrate microarray 
found aGal to be immune-reactive, but not the most immune-reactive glycan target (7). 
Interestingly, rhamnose, galactose-x-galactose and β1,4 linked mannose bound more 
antibody than aGal. With so many human antibodies directed towards carbohydrate targets 
present in the serum of healthy individuals it seems likely that the GGTA1/CMAH knockout 
pigs may bear additional carbohydrate epitopes that could be genetically modified to benefit 
xenotransplantation.
Matrix-assisted laser desorption/ionization (MALDI) followed by one or two time of flight 
(TOF) stages of mass spectrometry analysis is a very sensitive technique that can be used to 
determine the mass-to-charge ratios (m/z) of ions in simple or complex samples. This 
technology has been used effectively to uncover differences among healthy people and those 
with cancer by measuring changes to the N-linked glycans harvested from serum proteins 
(8,9). Changes to the N-linked glycans correlated to those patients in whom disease had 
progressed. The N-linked glycans of serum proteins have been representative of glycan 
changes in organs important to xenotransplantation (10). In fact most serum glycoproteins 
originate from the liver (11,12). This suggests that serum glycoproteins may represent a 
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readily available and efficient source for human and pig glycans. MALDI-TOF/TOF has 
also been used to define the composition of N-linked glycans present on human embryonic 
stem cells and human innate immune cells (8,13). The MALDI-TOF and TOF/TOF of native 
branched and sialylated acidic glycans can be improved by conversion to their methylated 
derivatives. Reduced and permethylated N-linked glycans ionize more efficiently than native 
glycans and give more detailed structural data when fragmented by collision-induced 
dissociation (9,14,15). These modifications can be carried out with as little as 1 μl of serum 
facilitating the processing of multiple samples simultaneously on micro scale (9).
In this study we reduced and permethylated the N-linked glycans of serum proteins from 
humans, domestic pigs, GGTA1 knockout pigs and GGTA1/CMAH knockout pigs. 
Modified glycans were analyzed in positive ion mode using a MALDI-TOF/TOF mass 
spectrometer (Figure 1). We determined that the serum N-linked glycomes of humans and 
pigs are reproducible and highly diverse. The data demonstrated the presence of known 
xenoantigens in domestic pigs and highlighted several differences between the glycans of 
humans, domestic and genetically modified pigs.
MATERIALS AND METHODS
Materials
The enzyme PNGase F, detergents, liquid chemical reagents, sodium hydroxide beads and 
high pressure liquid chromatography (HPLC) grade water were purchased from Sigma 
Chemical Co. (St. Louis, MO). Empty microspin columns were purchased from Harvard 
Apparratus (Holliston, MA) and graphitized carbon column for glycan purification were 
from Y-Carbon (Norristown, PA). The MALDI matrix, 2,5-dihydroxybenzoic acid, was 
purchased from Protea Biosciences (Morgantown, WV).
Serum samples
Blood samples were collected from healthy humans of blood type A, Landrace predominant 
mix breed pigs, GGTA1 knockout pigs, or GGTA1/CMAH knockout pigs using Institutional 
Review Board and Institutional Animal Care and Use Committee approved protocols (IRB 
#0808-60 and IACUC# 10345) (Figure 1A). Blood was collected into sterile non-
heparinized Vacutainer tubes and allowed to clot for 30 minutes at room temperature. The 
upper serum layer was collected, cleared by centrifuged, and stored at −80 °C until use.
Purification of N-linked glycans
Human or pig serum proteins (200 μL of serum) were diluted to 800 μL with a 10 mM 
sodium phosphate (pH = 7.5) containing 0.1% β-mercaptoethanol, and 0.1% SDS and 
incubated at 60 °C for 60 min. The N-linked glycans were enzymatically cut from the 
denatured and reduced proteins using 5 mU of PNGase F and incubating the samples for 24 
h at 37 °C (Figure 1B). The released glycans were purified by removing deglycosylated 
proteins on graphitized carbon columns. The graphitized carbon was activated with three 1 
mL aliquots of 85% acetonitrile (ACN)/15% H2O/0.1% trifluoroacetic acid (TFA) (solution 
A), and equilibrated with three 1 mL aliquots of 5% ACN/95% H2O/0.1% TFA (solution 
B). The samples were diluted to 4 mL with solution B, then loaded onto the graphitized 
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carbon column, collected by centrifugation, and reapplied to the same material a total of 3 
times. The column was washed 6 times with 5-mL solution B. Glycans were eluted using 
three 1 mL aliquots of a solution A. Each sample was then fractionated into 4 equal aliquots 
and dried using a vacuum centrifuge. Completely dried glycans were resuspended in 1ml of 
10mg/ml ammonia-borane complex made with HPLC grade H2O and heated to 60°C for 60 
minutes. Samples were cooled to room temperature, excess ammonia-borane complex was 
disrupted by the addition of three 200 μL aliquots of glacial acetic acid, added over a 3 h 
time period with mixing. After drying by vacuum centrifugation, borate salts were evolved 
as their methyl esters by the addition of three 1 mL aliquots of HPLC grade methanol, 
followed by drying vacuum centrifuge between additions.
Solid-phase extraction and reduction
The N-linked glycans from each analysis were permethylated statically following the 
protocol of Mechref et al and Alley et al. (9,15) in N,N-dimethylformamide (DMF) (Figure 
1C). Briefly, spin-columns were filled with sodium hydroxide beads suspended in ACN. The 
spin columns were washed 3 times with 1 mL DMF. Dried glycan samples were 
resuspended in 250 μL DMF, 90 μL methyl iodide, and 18 μL H2O. Samples were then 
applied to individual spin columns and incubated for 15 min at room temperature. Samples 
were collected by centrifuged at low speed, 90 μL of methyl iodide was added and re-
applied to the spin column for an additional 15 minutes and collected by centrifugation. Spin 
columns were rinsed with 500 μL ACN and added to samples. Permethylated glycans were 
recovered by a 4 mL chloroform extraction and washed by inversion with 4 mL 0.5 M NaCl 
solution in HPLC-grade water. Following the extraction, the chloroform layer was divided 
into 4 aliquots and dried in a vacuum centrifuge. Dried, reduced, and permethylated glycans 
were used immediately or stored at −80°C.
MALDI TOF/TOF analysis
Prior to MALDI-TOF analysis, the samples were reconstituted in a 40 μL 0.2% TFA in 
HPLC grade H2O. Graphitized carbon pipet tips (Sigma Chemical Co., St. Louis, MO) were 
activated and equilibrated as described above for columns. Glycans were eluted three times 
from graphitized carbon pipet tips with 0.5 μL 90% methanol and 10% H2O sequentially 
onto a stainless steel MALDI plate prespotted with 0.5 μL 10 mg/mL 2,5-dihydroxybenzoic 
acid in a 50% H2O, 50% methanol solution and 1 mM sodium acetate (to promote sodium 
adduct formation) with spot drying between elutions. A final elution with 0.5 μL of 100% 
ACN was layered onto each dry sample spot. Samples were spotted in duplicate. The 
samples were investigated manually using an Applied Biosystems Sciex 5800 MALDI-
TOF/TOF mass spectrometer (Framingham, MA) in positive-ion mode, with a ion range of 
1000 to 5000 m/z with a focus of 2500 m/z. A total of 5000 laser shots were acquired for 
each sample spot. Mass spectra were baseline corrected, noise removal applied, and peak 
analyzed with Data Explorer software (AB Sciex, Framingham, MA).
Structural determination
Mass spectra were annotated with GlycoWorkbench software (16), Cartoonist MS/MS2 
(Palo Alto Research Center, Palo Alto, CA,(17)) and SimGlycan v4 (Premier Biosoft, Palo 
Alto, CA) following the manufacturers tutorials or suggestions and using the nomenclature 
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proposed by the Consortium for Functional Glycomics (18). Briefly, T2D or Txt files were 
opened in the software and peaks were searched by all available databases. Structural 
annotations were species matched and considered potentially correct annotations. MALDI-
TOF/TOF mass spectra were opened in GlycoWorkbench and peaks were annotated with all 
possible structures for a given ion. The MALDI-TOF annotation was used a guide to 
determine the possible fragment ions observed in MALDI-TOF/TOF analysis. Final 
annotations (Figures 3 and 4) were based on a combination of MALDI-TOF and TOF TOF 
mass spectra and assistance from all three softwares. The MALDI-TOF/TOF annotations 
used the nomenclature proposed by Domon and Costello (19) without cross ring 
fragmentation (Figure 1D).
Statistical analysis
Paired one-tailed T-test with Graphpad Prism software (GraphPad Software Inc., La Jolla, 
CA) were used to determine the significance percent relative intensity differences between 
human and pig samples. Significance was < p=0.05 where indicated (Figure 6). The percent 
relative intensity was calculated from each spectral intensity normalized to the most 
abundant mass in that spectra set to 100 percent.
RESULTS
Serum protein glycome
The major surface antigens of pig cells in regards to xenotransplantation have been 
carbohydrates. The N-linked glycans of serum proteins are a reflection of organism-wide 
glycosylation patterns and are a plentiful source of carbohydrates from both humans and 
pigs. Asparagine linked glycans from humans, domestic pigs, GGTA1 knockout pigs and 
GGTA1/CMAH knockout pigs were removed by PNGaseF and isolated by selective 
retention and elution from graphitized carbon columns. This technique irreversibly bound 
the sample protein and allowed elution of free N-linked glycans. Glycans were stabilized by 
reduction and permethylation enabling the consistent collection of whole ion and fragmented 
ion mass spectra. Complete permethylation was verified by the absence of partially-
permethylated −14 Da ions preceding the most abundant ions in the spectra. This is 
demonstrated by the absence of ion 1581.8 m/z 14 Da downstream of ion 1595.8 m/z, Man5 
(Figure 2 black arrow). The ions derived from MALDI-TOF analysis were singly charged 
and sodiated ([M + Na]+). Although no potassium was included in matrix or sample buffer it 
is possible that [M + K]+ could occur as a contaminant during permethylation. Electro spray 
ionization often gives rise to K adducts but MALDI using the matrix 2,5-dihydroxybenzoic 
acid in the presence of 1 mM sodium acetate typically creates [M + Na]+ adducts. Never the 
less, we investigated the Man5 peak for a +16 Da ion that would be indicative of a K adduct 
instead of Na adduct and did not find one (Figure 2 grey arrow). It is possible, however, that 
non-sialylated glycans form adducts differently that sialylated glycans. We looked for an 
upstream +16 Da ion from sialylated glycans and found that in human samples 2808.3 and 
3237.7 m/z had +16 Da ions upstream while ions 2447.1, 3257.6 and 3792.9 m/z had ions 
+17 or +18 Da upstream. If potassium adducts were present in our samples we would expect 
them to be more consistent and therefore all of the structures assigned were sodiated. 
Tentative glycan structures were derived from database searches using GlycoWorkbench 
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(16), Cartoonist (17) and SimGlycan (20). MALDI-TOF/TOF fragmentation ion patterns 
were analyzed manually and with GlycoWorkbench software to verify potential glycan 
structures (16). The N-linked glycan analysis was divided into low range (1000 to 3100 m/z) 
and high range (3100 to 4500 m/z) spectra due to relative difference in spectral intensity. 
The glycan structures shown are correct in composition and antennae but may have 
positional isomers of sialylation or fucosylation that cannot be accounted for with the 
current technology.
Human serum protein glycome
MALDI-TOF/TOF analysis resulted in the assignment of 39 human glycan structures 
(Figures 3A and 4A). Low range spectra (n=3) were predominantly composed of ion 2808.3 
m/z annotated as hex5,hexNAc4,neuAc2 a bi-antennary N-linked glycan without core 
fucosylation (Figure 3A). High range spectra (n=3) were predominantly composed of ion 
3618.8 annotated as hex6,hexNAc5,neuAc3 a trianntenary N-linked glycan without core 
fucosylation (Figure 4A). Mass spectra of human samples contained a minority of 
mannosylated core glycans and truncated N-linked glycans or partial synthesis products by 
comparison. Peak ion 2808.3 was found in pig and human samples. Peak ion 3618.8 was 
unique to the human glycan samples. High range glycans were more prevalent in the human 
samples and contained complex tri and tetra antennary structures. The ions 3564.1 
(hex6,hexNAc5,dhex1,neuGc2), 3708.6 (hex5,hexNAc5,neuGc3) and 4432 
(hex8,hexNAc8,neuAc1,neuGc1) were suggested to contain terminal neu5Gc and was 
supported by MALDI-TOF (Figure 4A) and TOF/TOF fragmentation analysis (not shown). 
High mass glycans were more prevalent in all human samples. There were no significant 
differences in sialylation patterns between humans and pigs for the annotated glycans 
(Figure 3 and 4). High mass glycans among humans and pigs were observed to contain up to 
3 neuAc saccharides (3792.9 m/z human Figure 4A). These comparisons were made without 
bias for the structures we expected to see absent from the genetically modified pigs. There is 
the potential for blood group or unique antigens to occur as a heterogeneous population of 
glycans but this technology cannot differentiate those structures from a single mass. 
Therefore, annotation was based on the most abundant peaks in the fragmentation spectra 
and those most prevalent in the available databases. Fragmentation data suggest that more 
than one sialic acid on any bi-antennary glycan could be in series or parallel on antennae as 
indicated by fragment ions 344.2 [H+] annotated as Z-neuAc-B and 376.2 [H+] annotated as 
neuAc-B (Figure 5D). Thus annotations with more than one neuAc should be considered 
variable as depicted in Figures 3 and 5.
Porcine serum protein glycome
MALDI-TOF/TOF fragmentation analysis resulted in the assignment of 37 domestic pig, 36 
GGTA1 knock out pig and 34 GGTA1/CMAH knockout pig glycan structures (Figures 3B, 
C, D and 4B, C, D). The domestic and genetically modified pigs produced similar glycan 
profiles. Overall, mannosylated glycans were more prevalent in the pig samples as compared 
to humans. Ion 1362.7 (hex3,hexNAc2,dhex1) annotated as a core fucosylated N-linked 
glycan, was only present in pig samples and more abundant in genetically modified pigs. Ion 
1595.6 (hex5,hexNAc2) a core N-linked glycan bearing 5 mannose saccharides (Man5) was 
present in humans but increased significantly from domestic pigs to the GGTA1/CMAH 
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knock out pigs (n=3, P<0.05) (Figure 3 and 6). Fragmentation of ion 1595.6 gave rise to ions 
187 [H+], 316.2 [Na+], 490.3 [Na+], 839.5 [Na+], 1075.7 [Na+], 1302.7 [Na+], and 1377.6 
[Na+] that corresponded to the proposed structure (Figure 5A). The other high-mannose 
containing glycans, Man6 and Man7, were more abundant in pigs than human samples. 
These findings excluded Man9, which appeared equally present in human and genetically 
modified pig samples (Figure 3 and Table 1).
Pig samples had an accumulation of incomplete or truncated glycans as indicated by ions 
1677.7 (hex3,hexNAc4), annotated as an N-linked glycan, 1851.8 (hex3,hexNAc4,dhex1) a 
fucosylated N-linked glycan and 2055.8 (hex4,hexNAc4,dhex1) annotated as a fucosylated 
N-linked glycan with a single terminal galactosylation (Figure 3 B, C and D). Fragmentation 
of ion 1851.7 gave rise to ions 260.1 [H+], 490.3 [Na+], 676.3 [Na+], 921.4 [Na+], 1125.5 
[Na+], 1384.6 [Na+], and 1592.8 [Na+] that corresponded to the proposed structure (Figure 
5B).
Ion 2245.8 (hex5,hexNAc4,pen1) was annotated as an N-linked glycan structure with a core 
xylose and present in human and pig samples (Figure 3). Ion 2245.8 was present in only 1 of 
the human samples and appeared to increase in relative intensity with genetic modifications 
in pigs (n=3, P<0.05) (Figure 5C). Fragmentation of ion 2245.8 gave rise to ions 187 [H+], 
197 [Na+], 472.2 [Na+], 490.3 [Na+], 866.5 [Na+], 1316.6 [Na+], 1764.8 [Na+], 1779 [Na+], 
1783.1 [Na+] and 1796.8 [Na+] corresponded to the proposed structure (Figure 5C). We 
cannot determine the actual position of xylose due to isomerism but based on fragmentation 
data and existing database entries a beta-1,2 linkage (from plants) to a core mannose was 
shown.
The ions 2621.2 (hex5,hexNAc4,dhex1,neuAc1) and 2982.2 (hex5,hexNAc4,dhex1,neuAc2) 
were two of the most prevalent in pig samples. Ion 2621.2 and 2982.2 were minority peaks 
in human samples and corresponded to non-fucosylated structures which were the most 
prevalent low mass peaks in human samples (Figure 3). Ion 2982.2, the core fucosylated 
version of ion 2808.2 (hex5,hexNAc4,neuAc2), was significantly more abundant in all of 
the pig samples as compared to humans (n=3, P<0.05) (Figure 5D). Fragmentation of ion 
2982.2 gave rise to ions 376.2 [H+], 490.3 [Na+], 847.4 [Na+], 1333.8 [Na+], 1691.0 [Na+], 
2158.2 [Na+], 2516.3 [Na+] and 2607.6 [Na+] corresponded to the proposed structure 
(Figure 4D). This was also observed in human ions 2447.1, 3257.6, and 3618.8 and pig ions 
2621.2, 3431.7 and 3792.8, respectively (Figures 3 and 4). Table 1 summarizes the 
identified ions for human, domestic, GGTA1 and GGTA1/CMAH pigs with the observed 
masses and proposed structures shown in Figures 3 and 4. The absence of an ion m/z in 
Table 1 indicates either an unidentified ion peak or no detection of that ion m/z.
DISCUSSION
Preformed human antibodies directed towards carbohydrate epitopes continue to be a barrier 
to successful xenotransplantation. The generation of GGTA1/CMAH knock out pigs has 
reduced but not eliminated the impact of human antibody mediated cytotoxicity in vitro (4). 
In an effort to further reduce human antibody binding in genetically modified pigs, we 
characterized the serum protein glycome of humans and the pigs we hope will be a solution 
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to the human organ shortage. Our annotation of the human and pig N-linked glycomes 
corroborated several previous annotations of cellular and serum proteins (8,9,21,22). The 
majority of annotated structures provided in Figures 3 and 4 matched those entered in 
existing databases and many were validated by MALDI-TOF/TOF analysis (not shown). 
Structures, however, contain positional isomers that could significantly alter the 
immunoreactivity of a glycan. We made a concerted effort to remain unbiased regarding the 
genetic modification of the pigs when evaluating positional isomers resulting in perhaps an 
under-representation of blood groups involving sialylation and/or fucosylation of glycan 
antennae in contrast to core structures. We did, however, identify ion 2465.2 
(hex6,hexNAc4,dhex1) annotated as bearing a terminal gal/gal oligosaccharide, present in 
humans and domestic pigs but absent in GGTA1 knockout and GGTA1/CMAH knockout 
pigs (Table 1). This ion may represent alpha or beta linkages other than aGal in humans but 
inclusive of aGal in pigs. The loss of ion 2465.2 is supported by our previous 
characterization of the GGTA1 knockout pigs lacking the aGal epitope (23). The existing 
MALDI-TOF technology has limitations, as the absence of ion 2465.2 in GGTA1 and 
GGTA1/CMAH pigs cannot be fully attributed to genetic modification without further 
analysis, such as two-dimensional nuclear magnetic resonance. We also identified several 
masses in humans that contained neu5Gc and were validated by the presence of mass 
fragments that could only be possible with the inclusion of the mass representing sodiated 
and permethylated neu5Gc. This was not surprising since neu5Gc can be incorporated onto 
human N-linked glycans from dietary sources (24). Further analysis is needed to clarify if 
dietary incorporation of neu5Gc explains the terminal sialic acid of ions 3012.4 and 3345.6 
in pigs. Because we could identify previously described xenoantigens in human and 
domestic pig mass spectra, we felt confident that the discovery of N-linked glycans more 
abundant or unique to the GGTA1/CMAH knockout pigs may represent, at least in part, 
potential targets for further genetic modifications.
Quantitation of unmodified or native glycans by mass spectrometry has proven challenging 
due to instability and unpredictable fragmentation. Wada and colleagues and more recently 
Alley and colleagues have improved relative quantitation and fragmentation using protocols 
to stabilize glycans by reduction and permethylation (9,14). While mass spectrometry of the 
type used in this study is not fully quantitative we have established a relative quantitation 
based on the strength of the permethylated glycan ion signal of MALDI-TOF spectra across 
identically processed samples and/or limited mass range (14). We reduced and 
permethylated the glycan samples and limited the mass range of analysis in an attempt to 
provide a relative percent intensity that could be compared between spectra.
Asparagine-linked glycans are produced from a glucosylated high mannose precursor on the 
inner surface of the endoplasmic reticulum (ER) that is necessary for proper protein folding. 
This glc3man9glcNAc2 is then de-glucosylated resulting in man9 which we found equally 
abundant in human and pig samples (25). The N-linked glycan attached to the properly 
folded protein undergoes glycoprotein specific modification in the lumen of the ER and 
Golgi controlled by waves of de-glycosylating enzymes such as mannosidase and surges of 
glycosyltransferases such as alpha 1,3 galactosyl transferase. Failure to make the correct 
glycosylation changes or maintain correct protein folding, results in shuttling back to the ER 
or earlier Golgi for re-glycosylation and re-folding. We observed that pig samples with a 
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mutated GGTA1 or GGTA1 and CMAH genes had higher relative amounts of mannosylated 
and truncated glycans than human samples. It is difficult to correlate these relative changes 
to a loss of the GGTA1 enzyme or lack of expression of CMAH enzyme, but we 
hypothesize that the loss of the GGTA1 enzyme in the glyco-synthetic pathway of the golgi 
creates a partial barrier to further glycosylation resulting in a pool of incomplete glycans 
leading to higher mannosylation and exposed terminal N-acetylglucosamines (glcNAc) on 
core N-linked glycans. This has proven true in genetic modifications of the yeast glycan 
biosynthetic pathway creating an excess of man5 (26). The accumulation of truncated 
glycans is also associated with congenital disorders of glycosylation. Patients with a 
mutation in the ALG9 gene also accumulate high mannose and truncated glycans that affect 
protein transfer efficiency, the quality control of newly synthesized glycoproteins and can 
lead to premature degradation of truncated glycoproteins (27). We do not see an obvious 
pathology in the GGTA1/CMAH knockout pigs that could be related to the symptoms of 
patients with the ALG-9 defect. In fact, glycan microarray analysis of human antibody 
binding indicated that recognition of simple mannosylated glycans was on the lowest end of 
their scale (7). With that said, asymptomatic accumulation of Man3, Man5, Man6, Man7, 
Man8 and truncated glycans with one or two exposed glcNAc may reduce fecundity and 
peak function of organ systems. Further studies may show that genetic modification induced 
incomplete glycan synthesis may require a new strategy for silencing the genes producing 
already proven xenoantigens such as aGal. One alternative has been to express the human 
α1,2 fucosyltransferase gene in pigs to create an environment where gal α1,3 gal could be 
fucosylated to become the human blood group H antigen (28,29). Conversion of aGal to the 
H antigen with concomitant expression of human complement regulatory proteins may 
inspire new strategies to overcome the accumulation of high mannose and truncated glycans 
suggested by this study. This approach has proven successful in vitro and in vivo creating 
cells and organs that are less damaged by antibody-mediated rejection or survive longer after 
transplantation to non-human primates (28–30). Unfortunately, not all aGal was fucosylated 
and it is unclear if incomplete production of the H antigen was tissue specific, related to the 
promoter, or further modified by endogenous expression of fucosidases in the golgi (30). A 
better understanding of the glycan differences between humans and pigs may lead to 
additional transgenes as an alternative to knocking out multiple genes.
Xylose in mammals is found on O-linked glycans, in the construction of 
glycosaminoglycans, heparin and chondroitin sulfate and can occur in the ER, Golgi or 
serum by xylosyltransferase I and II (31,32). The occurrence of a core linked xylose on 
mammalian N-linked glycans has yet to be observed which is why we were surprised to 
identify an N-linked glycan of mass 2245.8 whose fragmentation pattern corresponded to 
several xylose containing structures (Figure 5). We repeated the glycan isolation protocol, 
MALDI-TOF and TOF/TOF analyses several times with the same result. It is possible that 
xylose containing N-linked glycans result from a combination of an abundance of truncated 
glycans in the presence of a rich source of dietary xylose. There is no evidence that 
xylosyltransferases are up regulated in pigs but a diet high in plant xylose may create a 
scenario similar to that of the incorporation of dietary neu5Gc in humans (24). Cultured cells 
secrete up to 90% of xylosyltransferase activity to the culture media (33). Therefore, if the 
majority of xylosyltransferase occurs in serum then high concentrations of dietary xylose 
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may impact xeno-reactivity. The presence of xylose on the ion 2245.8 may elicit human IgG 
and IgE antibody binding based on studies of plant allergens associated with plant pollen 
and peanut allergens (34). If pig xylosylation can be verified, it may become important to 
test individuals for anti-xylose antibodies prior to xenotransplantation. It is hard to imagine 
immunoreactivity to a glycan that is present in both humans and pigs. This may be explained 
by antigen density as we have shown in this study (Figure 6), or species-specific 
modifications to the mannose core where xylose is attached shielding antibody binding (34). 
Upregulation of xylosyltransferase in humans has been associated with osteoarthritis, 
systemic sclerosis and nephropathy in type 1 diabetes (33,35,36). The immune-reactivity of 
xylose on mammalian glycans, concentration and availability of enzyme and substrate need 
to be verified before further genetic modifications in pigs should be considered.
Similar to beta 1,2 linked xylose, fucosylation can be a target of human antibody when 
linked alpha 1,3 to a N-linked glycan core glcNAc or as part of disparate blood group 
antigen (7,37). We identified the most abundant glycan in human samples (2808.3 m/z) and 
all of the pig samples (2982.2 m/z) as a bi-antennary complex type glycan with terminal 
neuAc (Figure 2). The difference in mass was due to a fucosylation of the core glcNAc in all 
of the pig samples (Figure 5D). The presence of fragments indicative of core fucosylation 
(490.3 m/z) substantiates our proposed structure for this ion but there may be positional 
isomers that would present the fucose as a terminal blood group or other antennae linkage. 
As a trend among all samples tested increased fucosylation was the most striking difference 
between human and pigs but perhaps challenging to address with regard to 
xenotransplantation. Mice lacking alpha 1,3 fucosyltransferase have a loss of the lewis X 
structure but have significant psychological changes and may alter the sensory nervous 
system (38,39).
This study has presented the human and pig serum protein glycomes and in the interest of 
xenotransplantation, the glycomes of pigs lacking two carbohydrate xenoantigens. Four 
important observations emerged. The GGTA1/CMAH knockout pigs had more: 
mannosylated N-linked glycans, incomplete glycan synthesis, xylosylated N-linked glycans, 
and fucosylation of existing bi- and tri-antennary N-linked glycans. Further studies of the 
individual glycans are necessary to determine the impact of these carbohydrates on 
xenotransplantation.
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ABBREVIATIONS
AMR Antibody-mediated rejection
MALDI-TOF Matrix-assisted laser desorption/ionization time-of-flight
aGal galactose α-1,3 galactose
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neu5Gc N-glycolyl neuraminic acid
neu5Ac N-acetyl neuraminic acid
CMAH cytidine monophosphate-N-acetylneuraminic acid hydroxylase
ER endoplasmic reticulum
HPLC high pressure liquid chromatography
ACN acetonitrile
TFA trifluoroacetic acid
DMF N,N-dimethylformamide
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Figure 1. Workflow for the discovery of human and porcine glycans
A. This study compares the N-linked glycomes of humans, domestic pigs, GGTA1 knockout 
pigs and GGTA1/CMAH knockout pigs. B. Serum samples were treated with the 
deglycosylating enzyme, PNGaseF, to remove N-linked glycans from serum proteins. C. 
Native glycans were stabilized by reduction and permethylation on solid-phase sodium 
hydroxide spin columns. D. Collision induced dissociation of permethylated glycans 
resulted in predictable fragmentation that was analyzed using the nomenclature of Domon 
and Costello (19).
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Figure 2. 
MALDI-TOF MS profile of ion 1595.8, Man5. Incomplete permethylation results in 
predictable ions 14 Da downstream of a fully permethylated ion. The black arrow points to 
the absence of ion 1581.8 m/z, −14 Da from ion 1595.8 m/z. The grey arrow indicates the 
absence of ion 1611.8 m/z, a +16 Da ion that could originate from the formation of a 
potassium adduct instead of the more common sodium adduct.
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Figure 3. 
MALDI-TOF MS profiles of the permethylated N-linked glycans from human (A), domestic 
pigs (B), GGTA1 knockout pigs (C) and GGTA1/CMAH knockout pigs in the range of 1000 
to 3100 m/z. Major peaks are annotated with their proposed carbohydrate structures using 
the nomenclature proposed by the consortium for functional glycomics (18).
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Figure 4. 
MALDI-TOF MS profiles of the permethylated N-linked glycans from human (A), domestic 
pigs (B), GGTA1 knockout pigs (C) and GGTA1/CMAH knockout pigs in the ion range of 
3100 to 4500 m/z. Major peaks are annotated with their proposed carbohydrate structures 
using the nomenclature proposed by the consortium for functional glycomics (18).
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Figure 5. 
MALDI-TOF/TOF MS fragmentation profiles for the reduced and permethylated N-linked 
glycans of the GGTA1/CMAH knockout pig. The ions 1595.7 (A), 1851.8 (B), 2245.8 (C) 
and 2982.2 (D) were more abundant in the GGTA1/CMAH knockout pigs samples. Major 
peaks were annotated with their proposed structures based on the proposed carbohydrate 
structures using the nomenclature of the Consortium for Functional Glycomics (18). The 
complete N-linked glycan structure is shown to the left of the MS spectra.
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Figure 6. 
MALDI-TOF/TOF MS fragmentation of N-linked glycans at 1595.7 (A), 1851.8 (B), 2245.8 
(C) and 2982.2 (D) were compared between human, domestic pigs, GGTA1 knockout pigs, 
and GGTA1/CMAH knockout pigs as the percent of relative intensity (n=3). Statistically 
significant differences were indicated with an asterisk (P<0.05, paired one tailed T-test). 
Complete structures as determined from MALDI-TOF/TOF analysis are shown to the left of 
each panel.
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Table 1
N-linked glycans detected in this study. The observed masses for human, domestic, GGTA1 and GGTA1/
CMAH pig serum N-linked glycans are listed by ascending ion m/z.
Human Domestic GGTA1 CMAH/GGTA1
1362.7 1362.7 1363.2
1595.8 1595.8 1595.7 1595.7
1677.7 1677.7 1677.7
1799.8 1799.7 1799.7 1799.7
1851.8 1851.7 1851.7 1851.7
1881.7 1881.7 1881.7
2003.9 2003.7 2003.7 2003.7
2055.9 2055.8 2055.8 2055.8
2085.9
2157.9 2157.9 2157.9
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Human Domestic GGTA1 CMAH/GGTA1
2208.1 2207.9 2207.9 2207.9
2245.8 2245.8 2245.8
2260 2259.8 2259.8 2259.8
2412 2412 2412 2412
2433.1 2433.1 2433.1 2433.1
2447.1 2447 2447 2447
2463.9 2465.2
2505.2
2607 2607 2607
2621.2 2621.2 2621.2
2651.1 2651.1
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Human Domestic GGTA1 CMAH/GGTA1
2794.2 2794.2 2794.2 2794.2
2808.3 2808.2
2824.3 2826.4
2866.2
2946.4 2946.4 2946.4
2982.2 2982.2 2982.2 2982.2
3012.4 3012.4 3012.4
3070.4 3070.4
3134.5 3134.5 3134.5
3187.1
3214.8
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Human Domestic GGTA1 CMAH/GGTA1
3227.7 3228.3
3243.6
3257.6
3274.6
3288.6 3288.6
3345.6 3345.6 3345.6
3376.8 3376.8 3376.8
3417.5 3417.4 3417.4 3417.5
3431.7 3431.7 3431.7 3431.7
3462.5 3462.5
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Human Domestic GGTA1 CMAH/GGTA1
3564.1
3605.7
3618.8
3708.6
3738.5 3738.5 3738.5
3779.7 3779.5 3779.5 3779.5
3792.9 3792.8 3792.8 3792.8
3813.7
3822.9 3822.9
3883.4
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Human Domestic GGTA1 CMAH/GGTA1
4057.4
4069.8
4244.2 4243.8 4243.8 4243.8
4418.4
4432
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